Streetbeat News

Equity Actions

NYCB

Former Treasury Secretary Steven Mnuchin and a group of investors have invested over $1 billion in New York Community Bancorp Inc (NYSE:NYCB), aiming to transform it into a 'very attractive' regional bank. Mnuchin will join the board, and Joseph Otting will become CEO. The investment is seen as a lifeline but is 'tremendously dilutive' to shareholders. NYCB's shares rose 6.65% to $3.68 following the announcement.

Portfolio Pulse from Adam Eckert

March 07, 2024 | 5:36 pm

ABNB

AMZN

CAVA

JMIA

LULU

MELI

PVH

SHAK

TSLA

WYNN

Today's session highlighted significant options activity for 10 consumer discretionary stocks, indicating potential trading opportunities based on whale alerts. These alerts, tracking large transactions, suggest varied sentiments across the stocks, with notable bearish and bullish positions on companies like TSLA, LULU, and AMZN among others. The activity spans a range of expiration dates and strike prices, reflecting diverse market expectations.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 5:35 pm

AAPL

ACMR

AVGO

CRWD

DELL

NOW

NVDA

PANW

SMCI

Today's session highlighted unusual options activity for several Information Technology stocks, indicating significant whale alerts. Notably, bearish sentiment dominated the call options for NVDA, MU, SMCI, DELL, AAPL, and PANW, while bullish sentiment was observed in AVGO, ACMR, and NOW call options, and CRWD put options. These activities suggest large investors' expectations on the future movements of these stocks, potentially impacting their short-term price direction.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 5:35 pm

DELL

Dell Technologies (NYSE:DELL) has seen unusual options activity, with a bearish sentiment from high-rolling investors. Benzinga's options scanner identified 33 trades, showing a split sentiment with 45% bullish and 54% bearish. The focus is on a price band between $50.0 and $160.0. Notable options activity includes both bearish and bullish calls with various expiration dates and strike prices. Dell's stock is up 0.68% at $119.3, with some analysts maintaining positive ratings despite a consensus target price of $108.4.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 5:31 pm

On a live CNBC segment, Josh Brown announced that he has sold his holdings in Zoom Video Communications (ZM).

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 5:31 pm

MCD

On a live CNBC segment, Josh Brown announced that he has sold his McDonald's stock. This move by a prominent investor could influence market perceptions and potentially impact McDonald's stock price in the short term.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 5:29 pm

NVDA

On a live CNBC segment, Brian Belski announced a trimmed position in Nvidia, indicating a change in investment strategy or outlook towards the company.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 5:17 pm

AHG

Akso Health Group (AHG) is offering 37.1 million ADS shares at $1.33 each to institutional investors, along with warrants for up to 222.6 million ordinary shares at an exercise price of $0.4933 per share. The offering is part of a Securities Purchase Agreement dated March 5, 2024. The warrants are exercisable immediately and expire in five years. This offering and the warrants are exempt from registration under the Securities Act of 1933. AHG's public float was valued at approximately $276.52 million based on a price per ADS of $2.60 as of February 2, 2024. AHG's ADSs are traded on the Nasdaq under the symbol "AHG", with a closing sale price of $1.23 per ADS on March 5, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 5:10 pm

REG

Analyst ratings for Regency Centers (NASDAQ:REG) show a mix of bullish to bearish sentiments, with recent updates indicating a positive shift in price targets. The average 12-month price target has risen by 3.97% to $72.00. Recent analyst actions include adjustments to ratings and price targets by firms such as Jefferies, Wells Fargo, Evercore ISI Group, Truist Securities, and Morgan Stanley. Regency Centers, a leading retail REIT, has shown notable revenue growth and market capitalization but faces challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 5:01 pm

CPRX

Four financial analysts have recently published diverse ratings on Catalyst Pharmaceuticals (NASDAQ:CPRX), with a mix of bullish and somewhat bullish perspectives. The average 12-month price target for CPRX has been raised to $27.75, indicating a positive outlook on the stock's future performance. Catalyst Pharmaceuticals, a biopharmaceutical company focusing on rare neuromuscular and neurological diseases, has shown impressive financial performance with significant revenue growth and strong financial health indicators such as net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 5:00 pm